Uptake and adherence to highly active antiretroviral therapy among HIV‐infected people with alcohol and other substance use problems: the impact of substance abuse treatment
- 18 February 2004
- Vol. 99 (3) , 361-368
- https://doi.org/10.1111/j.1360-0443.2003.00670.x
Abstract
We examined the association of substance abuse treatment with uptake, adherence and virological response to highly active antiretroviral therapy (HAART) among HIV-infected people with a history of alcohol problems. Prospective cohort study. A standardized questionnaire was administered to 349 HIV-infected participants with a history of alcohol problems regarding demographics, substance use, use of substance abuse treatment and uptake of and adherence to HAART. These subjects were followed every 6 months for up to seven occasions. We defined substance abuse treatment services as any of the following in the past 6 months: 12 weeks in a half-way house or residential facility; 12 visits to a substance abuse counselor or mental health professional; or participation in any methadone maintenance program. Our outcome variables were uptake of antiretroviral therapy, 30-day self-reported adherence and HIV viral load suppression. At baseline, 59% (205/349) of subjects were receiving HAART. Engagement in substance abuse treatment was independently associated with receiving antiretroviral therapy (adjusted OR; 95% CI: 1.70; 1.03-2.83). Substance abuse treatment was not associated with 30-day adherence or HIV viral load suppression. More depressive symptoms (0.48; 0.32-0.78) and use of drugs or alcohol in the previous 30 days (0.17; 0.11-0.28) were associated with worse 30-day adherence. HIV viral load suppression was positively associated with higher doses of antiretroviral medication (1.29; 1.15-1.45) and older age (1.04; 1.00-1.07) and negatively associated with use of drugs or alcohol in the previous 30 days (0.51; 0.33-0.78). Substance abuse treatment was associated with receipt of HAART; however, it was not associated with adherence or HIV viral load suppression. Substance abuse treatment programs may provide an opportunity for HIV-infected people with alcohol or drug problems to openly address issues of HIV care including enhancing adherence to HAART.Keywords
This publication has 48 references indexed in Scilit:
- Detecting Alcohol Problems in HIV-Infected Patients: Use of the CAGE QuestionnaireAIDS Research and Human Retroviruses, 2004
- Strategies for Optimizing Adherence to Highly Active Antiretroviral Therapy: Lessons from Research and Clinical PracticeClinical Infectious Diseases, 2001
- Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Association of Provider and Patient Characteristics With HIV-Infected Women's Antiretroviral Therapy RegimenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatmentAIDS, 2000
- Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study GroupJournal of Epidemiology and Community Health, 1999
- A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virusArchives of internal medicine (1960), 1995
- Rapid and Precise Quantification of HIV-1 RNA in Plasma Using a Branched DNA Signal Amplification AssayJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- “Mini-mental state”Journal of Psychiatric Research, 1975